0001483426-20-000006.txt : 20200803
0001483426-20-000006.hdr.sgml : 20200803
20200731201516
ACCESSION NUMBER: 0001483426-20-000006
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200803
DATE AS OF CHANGE: 20200731
EFFECTIVENESS DATE: 20200803
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MBio Diagnostics, Inc.
CENTRAL INDEX KEY: 0001483426
IRS NUMBER: 300593627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-372233
FILM NUMBER: 201067542
BUSINESS ADDRESS:
STREET 1: 3122 STERLING CIRCLE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 303-952-2863
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: mBio Diagnostics, Inc.
DATE OF NAME CHANGE: 20100204
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001483426
MBio Diagnostics, Inc.
5603 Arapahoe Avenue
Suite 1
BOULDER
CO
COLORADO
80303
303-952-2905
DELAWARE
mBio Diagnostics, Inc.
Corporation
true
Christopher
Myatt
5603 Arapahoe Avenue
Suite 1
Boulder
CO
COLORADO
80303
Executive Officer
Director
Andrew
Drenick
5603 Arapahoe Avenue
Suite 1
Boulder
CO
COLORADO
80303
Director
Robert
Silverman
5603 Arapahoe Avenue
Suite 1
Boulder
CO
COLORADO
80303
Director
Michael
Chang
5603 Arapahoe Avenue
Suite 1
Boulder
CO
COLORADO
80303
Director
Judith
O'Brien
5603 Arapahoe Avenue
Suite 1
Boulder
CO
COLORADO
80303
Director
Other
Decline to Disclose
- 06b
true
0001483426-20-000005
2020-07-17
false
true
false
0
11000000
6146350
4853650
Total amount sold includes the conversion of convertible promissory notes in the principal amount of $3,231,350.
false
16
0
0
0
false
MBio Diagnostics, Inc.
/s/ Christopher J. Myatt
Christopher J. Myatt
CEO, by Tyler Hayden, Attorney-in-Fact
2020-07-31